BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2020
View Archived Issues
SWI/SNF mutations can lead to gain of function
Read More
Lactose tolerance may be Red Herring
Read More
CXCR3 is a potential therapeutic target in pulmonary hypertension
Read More
Midatech presents phase I data for MTX-110 in diffuse intrinsic pontine glioma
Read More
Hinova Pharmaceuticals divulges new BRD4 and AR dual inhibitors
Read More
Betta Pharmaceuticals patents EGFR mutant inhibitors
Read More
Chinese researchers present new MAPK inhibitors
Read More
Positive interim data presented from phase III SHORELINE study of zuranolone in MDD
Read More
Yichang Humanwell Pharmaceutical synthesizes kappa-opioid receptor agonists
Read More
In extracellular space, intracellular protein fights sepsis
Read More
Intellia receives authorization to initiate first-in-human study of NTLA-2001 in the U.K.
Read More
Phanes Therapeutics discloses anti-claudin 18.2 CARs
Read More
NGM targets new immuno-oncology development candidate NGM-707 to enter clinic next year
Read More
Global phase II study of OT-101 for COVID-19 cleared for enrollment in Argentina
Read More
Approval of phase I study of bacTRL-Spike vaccine for prevention of COVID-19
Read More
VLS-101 enters phase II trial in previously treated solid tumors
Read More
CHRM3 unveiled as a therapeutic target in NSCLC
Read More
Discovery of novel highly potent ghrelin receptor full agonists
Read More
DeltaF508 CFTR cystic fibrosis models generated in Collaborative Cross mice
Read More
miRNA-646 and miRNA-4739 identified as schizophrenia markers
Read More
DSMB recommends progression of phase II trial of MAT-2203 for cryptococcal meningitis
Read More
New substudy evaluates Treadwell's CFI-400945 in metastatic CRPC
Read More
Aptinyx reports promising phase II data on NYX-783 in PTSD
Read More
